1,369 followers
RT @emiliomonteb: Cost-effectiveness of abatacept, rituximab, and TNFi after previous failure with TNFi in rheumatoid arthritis https://t.c…
RT @emiliomonteb: Cost-effectiveness of abatacept, rituximab, and TNFi after previous failure with TNFi in rheumatoid arthritis https://t.c…
RT @emiliomonteb: Cost-effectiveness of abatacept, rituximab, and TNFi after previous failure with TNFi in rheumatoid arthritis https://t.c…
Cost-effectiveness of abatacept, rituximab, and TNFi after previous failure with TNFi in rheumatoid arthritis https://t.co/vuI82yvxMZ
139TNFi failures switched to RTX, ABA, other TNFi- all equally effective. 80/139 cont Rx@1yr. RTX most cost effective http://t.co/zqJlwjJlNY